Hepatitis C Information Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Hep C information
Free Newsletter
Hepatitis C Newsletter
We value your privacy. We will not rent your email to anyone.
HEPATITIS NEWS
The top stories compiled from over 5,500 sources, updated every 15 minutes

New Model Allows Testing of Hepatitis C Treatments
'This is the first efficient and consistent model system for HCV to be developed,' Martina Buck, assistant professor of medicine at the University of California, San Diego, School of Medicine, who developed the culture, said in a university news release.

Natalie Cole Says She Has Hepatitis C
NEW YORK (AP) - Grammy-winning singer Natalie Cole has been diagnosed with hepatitis C, her publicist said in a statement Wednesday. Hepatitis C is a liver disease spread through contact with infected blood. The statement said the disease was revealed

Natalie Cole says she has hepatitis C (07/17/2008)
Grammy-winning singer Natalie Cole has been diagnosed with hepatitis C, her publicist said in a statement yesterday. Hepatitis C is a liver disease spread through contact with infected blood. The statement said the disease was revealed during a routine

UPDATES AND COMMENTARY RSS Feed

Hep C and Fatty Liver Disease Linked by Enzyme
Pittsburgh researchers have found that an enzyme known to participate in fat production is elevated in those with Hepatitis C. Further exploration of this enzyme could help physicians better predict which HCV patients are at risk of developing fatty liver...

ANA773 Resumes Race Against Hepatitis C
By reducing the dosing schedule in half, Anadys Pharmaceuticals returns to their investigation of ANA773, a Toll-Like Receptor-7 agonist prodrug. Approaching the Hepatitis C virus differently from most other contenders, Phase I clinical trials evaluating the safety, tolerability and viral-load...

Popular Illegal Drug Extra Harmful with HCV
Although scores of Americans are turning to the street drug methamphetamine to keep them awake and thin, scientists have found that it worsens Hepatitis C infection in two worrisome ways....

Cross-sectional and Longitudinal SurveyCirrhosis table of Contents

Arch Intern Med. 1999;159:49-52

"Close Relation Between Cirrhosis and Gallstones:
Cross-sectional and Longitudinal Survey"

Dario Conte, MD; Mirella Fraquelli, MD; Fabio Fornari, MD; Lucia Lodi, MD; Paolo Bodini, MD; Luigi Buscarini, MD

Background:

Increased gallstone prevalence and incidence in cirrhosis have already been reported in different series, including a limited number of patients with cirrhosis.

Objective:

To evaluate the frequency of gallstones and related risk factors in a large series of patients with cirrhosis.

Patients and Methods:

The cross-sectional study involved 1010 patients with cirrhosis related to alcohol abuse, chronic viral infection, or miscellaneous causes (42%, 48%, and 10%, respectively) in Child class A, B, or C (48%, 36%, and 16%, respectively). In the longitudinal study gallstone development was monitored ultrasonographically in 618 patients free of gallstones at enrollment.

Results:

The overall prevalence of gallstone(s) was 29.5% and increased significantly with age without differences according to sex or cause of cirrhosis. Multiple logistic regression analysis showed that only Child classes B and C were significantly related to a higher risk of gallstone (odds ratio, 1.63 for class C vs class A and 1.91 for class B vs class A; P=.001). During a mean ± SD follow-up of 50 months ± 9 months, 141 (22.8%) of 618 patients developed gallstone(s), with an estimated cumulative probability of 6.5%, 18.6%, 28.2%, and 40.9% at 2, 4, 6, and 8 years, respectively. Multivariate analysis showed that Child class (hazard ratio, 2.8 for class C vs class A and 1.8 for class B vs class A; P=.002 and P=.001, respectively) and high-body mass index (hazard ratio, 1.31; P=.04) carried a significantly greater risk of gallstone formation.

Conclusion:

Cirrhosis per se represents a major risk factor for gallstones whose prevalence and incidence were far higher than those reported in a general population from the same area.

  Hep C information

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

©1994-2008 Hepatitis-Central.com
Updated 19 Jul 2008